Distinct roles for basal and induced COX-2 in podocyte injury

Journal of the American Society of Nephrology

Volumn 20, Issue 9, 2009, Pages 1953-1962

  Cheng, Huifang ^a   Fan, Xiaofeng ^a   Guan, Youfei ^c   Moeckel, Gilbert W ^b   Zent, Roy ^a   Harris, Raymond C ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DOXORUBICIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 RECEPTOR 4; PROSTANOID RECEPTOR; THROMBOXANE B2; THROMBOXANE RECEPTOR; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DAMAGE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL SURVIVAL; CONTROLLED STUDY; FOOT; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; STRESS FIBER; WILD TYPE;

ALBUMINURIA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL ADHESION; CELL LINE, TRANSFORMED; CELL SURVIVAL; CYCLOOXYGENASE 2; DINOPROSTONE; DOXORUBICIN; GLOMERULONEPHRITIS; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PODOCYTES; PUROMYCIN; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE; RNA, MESSENGER; THROMBOXANES;

EID: 69849108783     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009010039     Document Type: Article

References (48)

1. Shankland, SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006 (Pubitemid 43882099)
2. Ichikawa I, Ma J, Motojima M, Matsusaka T: Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 14: 205-210, 2005 (Pubitemid 40685630)
3. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, Trzaskos JM: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995
4. Wang JL, Cheng HF, Zhang MZ, McKanna JA, Harris RC: Selective increase of cyclooxygenase-2 expression in a model of renal ablation. Am J Physiol 275: F613-F622, 1998 (Pubitemid 128735102)
5. Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, Anderson S: Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 107: 889-898, 2001 (Pubitemid 32274042)
6. Martineau LM, McVeigh LI, Jasmin BJ, Kennedy CR: p38 MAP kinase mediates mechanically-induced cyclooxygenase-2 and prostaglandin EP4 receptor expression in podocytes: Implications for the actin cytoskeleton. Am J Physiol Renal Physiol 286: F693-F701, 2003
7. Wang JL, Cheng HF, Shappell S, Harris RC: A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Kidney Int 57: 2334-2342, 2000 (Pubitemid 30340732)
8. Sanchez PL, Salgado LM, Ferreri NR, Escalante B: Effect of cyclooxygenase-2 inhibition on renal function after renal ablation. Hypertension 34: 848-853, 1999 (Pubitemid 29501311)
9. Horiba N, Kumano E, Watanabe T, Shinkura H, Sugimoto T, Inoue M: Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney. Nephron 91: 134-141, 2002 (Pubitemid 34522843)
10. Kong WX, Ma J, Gu Y, Yang HC, Zuo YQ, Lin SY: [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation]. Zhonghua Nei Ke Za Zhi 42: 186-190, 2003
11. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002 (Pubitemid 35386908)
12. Cheng H, Wang S, Jo YI, Hao CM, Zhang M, Fan X, Kennedy C, Breyer MD, Moeckel GW, Harris RC: Overexpression of cyclooxygenase-2 predisposes to podocyte injury. J Am Soc Nephrol 18: 551-559, 2007 (Pubitemid 46193320)
13. Jo YI, Cheng H, Wang S, Moeckel GW, Harris RC: Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Nephron Exp Nephrol 107: e87-e94, 2007 (Pubitemid 350073618)
14. Bek M, Nusing R, Kowark P, Henger A, Mundel P, Pavenstadt H: Characterization of prostanoid receptors in podocytes. J Am Soc Nephrol 10: 2084-2093, 1999
15. Trivedi DB, Sugimoto Y, Loftin CD: Attenuated cyclooxygenase-2 expression contributes to patent ductus arteriosus in preterm mice. Pediatr Res 60: 669-674, 2006 (Pubitemid 44789507)
16. Chamberlin M, Lozynski J: To go against nature: Manipulating the neonatal ductus arteriosus with prostaglandin. Newborn Infant Nurs Rev 6: 158-162, 2006 (Pubitemid 44276261)
17. 4 receptor through a PKA-independent mechanism. Cell Signal 20: 2156-2164, 2008
18. Weber TJ, Monks TJ, Lau SS: PGE2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptor. Am J Physiol 273: F507-F515, 1997 (Pubitemid 127751908)
19. 2) in the prevention of acute renal failure in anesthetized dogs. In situ renal preservation. Ren Fail 11: 27-31, 1989
20. Stenson WF: Prostaglandins and epithelial response to injury. Curr Opin Gastroenterol 23: 107-110, 2007
21. 2 promotes cell survival of glomerular epithelial cells via the EP4 receptor. Am J Physiol Renal Physiol 290: F1534-F1542, 2006
22. Hermann M, Shaw S, Kiss E, Camici G, Buhler N, Chenevard R, Luscher TF, Grone HJ, Ruschitzka, F: Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 45: 193-197, 2005 (Pubitemid 40179959)
23. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM: Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004 (Pubitemid 38174140)
24. 2 from glomerular thrombi in nephropathy with type 2 diabetic rats. Life Sci 72: 2695-2705, 2003
25. Xu S, Jiang B, Maitland KA, Bayat H, Gu J, Nadler JL, Corda S, Lavielle G, Verbeuren TJ, Zuccollo A, Cohen RA: The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 55: 110-119, 2006 (Pubitemid 43343305)
26. Sebekova K, Eifert T, Klassen A, Heidland A, Amann K: Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes. Diabetes 56: 968-974, 2007 (Pubitemid 46525071)
27. Michel F, Simonet S, Vayssettes-Courchay C, Bertin F, Sansilvestri-Morel P, Bernhardt F, Paysant J, Silvestre JS, Levy BI, Feletou M, Verbeuren TJ: Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice. Am J Physiol Renal Physiol 294: F120-F129, 2008
28. Boffa JJ, Just A, Coffman TM, Arendshorst WJ: Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol 15: 2358-2365, 2004 (Pubitemid 39159335)
29. Lariviere R, Moreau C, Rodrigue ME, Lebel M: Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats. Prostaglandins Leukot Essent Fatty Acids 71: 103-109, 2004 (Pubitemid 38881248)
30. Uriu K, Kaizu K, Hashimoto O, Komine N, Etoh S: Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin- induced diabetic rats. Kidney Int 45: 794-802, 1994 (Pubitemid 24094492)
31. Spurney RF, Fan PY, Ruiz P, Sanfilippo F, Pisetsky DS, Coffman TM: Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int 41: 973-982, 1992
32. Salvati P, Lamberti E, Ferrario R, Ferrario RG, Scampini G, Pugliese F, Barsotti P, Patrono C: Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis. Kidney Int 47: 1168-1175, 1995
33. Yoshida T, Kameda H, Ichikawa Y, Tojo T, Homma M: Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis. J Rheumatol 23: 1719-1724, 1996 (Pubitemid 26342441)
34. Perico N, Rossini M, Imberti O, Malanchini B, Cornejo RP, Gaspari F, Bertani T, Remuzzi G: Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft. J Am Soc Nephrol 2: 1398-1404, 1992
35. Spurney RF, Mayros SD, Collins D, Ruiz P, Klotman PE, Coffman T: Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats. Prostaglandins 39: 135-146, 1990 (Pubitemid 20070869)
36. Smith SR, Creech EA, Schaffer AV, Martin LL, Rakhit A, Douglas FL, Klotman PE, Coffman TM: Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. Kidney Int 41: 199-205, 1992
37. Zoja C, Perico N, Corna D, Benigni A, Gabanelli M, Morigi M, Bertani T, Remuzzi G: Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney. J Am Soc Nephrol 1: 799-807, 1990
38. Coffman TM, Ruiz P, Sanfilippo F, Klotman PE: Chronic thromboxane inhibition preserves function of rejecting rat renal allografts. Kidney Int 35: 24-30, 1989 (Pubitemid 19047420)
39. Schneider A, Guan Y, Zhang Y, Magnuson MA, Pettepher C, Loftin CD, Langenbach R, Breyer RM, Breyer MD: Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 40: 7-14, 2004 (Pubitemid 39655112)
40. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Podocyte-specific expression of Cre recombinase in transgenic mice. Genesis 35: 39-42, 2003 (Pubitemid 36150980)
41. Quaggin SE: A "molecular toolbox" for the nephrologist. J Am Soc Nephrol 13: 1682-1685, 2002
42. Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM: Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102: 1994-2001, 1998
43. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ: Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009
44. Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson BR, Saito Y, Betsholtz C: A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 161: 799-805, 2002 (Pubitemid 34988366)
45. Mundel P, Reiser J, Kriz W: Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 8: 697-705, 1997 (Pubitemid 27493583)
46. Shankland SJ, Pippin JW, Reiser J, Mundel, P: Podocytes in culture: Past, present, and future. Kidney Int 72: 26-36, 2007 (Pubitemid 47014453)
47. Cheng HF, Harris RC: Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms. Role of p38-mediated pathways. J Biol Chem 277: 45638-45643, 2002
48. Cai S, Bulus N, Fonseca-Siesser PM, Chen D, Hanks SK, Pozzi A, Zent R: CD98 modulates integrin β1 function in polarized epithelial cells. J Cell Sci 118: 889-899, 2005 (Pubitemid 40484881)